This week we highlighted findings from recently published cost-effectiveness studies:
- Apixaban therapy for atrial fibrillation provides clinical benefits at reasonable incremental cost: Apixaban compared with warfarin in patients with atrial fibrillation found to be reasonably cost-effective from the perspective of the US health care system. (4)
- Review of cost-effectiveness analyses reveals relations between screening and vaccinating against human papillomavirus (HPV) infection: Variations in screening practices and valence of HPV vaccination had the largest implications in terms of cost-effectiveness. (7)
See below for a full list of all cost-utility studies and selected reviews and editorials published March 20-31, 2017. To discover more CEA articles or to dive in-depth on some of these topics, please visit the Tufts CEA Registry. Follow us on Twitter (@TuftsCEVR) and Facebook.
1: Chan LH, Good DW, Laing K, Phipps S, Thomas BG, Keanie JY, Tolley DA, Cutress ML. Primary SWL Is an Efficient and Cost-Effective Treatment for Lower Pole Renal Stones Between 10 and 20 mm in Size: A Large Single Center Study. J Endourol. 2017 Mar 29. PubMed PMID:28355100.
2: Chau SH, Sluiter RL, Kievit W, Wensing M, Teichert M, Hugtenburg JG. Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands. Drugs Aging. 2017 Mar 30. PMID: 28361278.
3: Chong HY, et al. Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia. Br J Dermatol. 2017 Mar 27. PMID: 28346659.
4: Cowper PA, et al. Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol. 2017 Mar 29. PMID: 28355434.
5: Davis JC, et al. Economic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial. BMJ Open. 2017 Mar 29;7(3):e014387. PMID: 28360247.
6: Ferket BS, Feldman Z, Zhou J, Oei EH, Bierma-Zeinstra SM, Mazumdar M. Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative. BMJ. 2017 Mar 28;356:j1131. PMID: 28351833.
7: Gervais F, Dunton K, Jiang Y, Largeron N. Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend. BMC Public Health. 2017 Mar 28;17(1):283. PMID: 28351348.
8: Grimes CE, et al. Cost-Effectiveness of Two Government District Hospitals in Sub-Saharan Africa. World J Surg. 2017 Mar 27. PMID: 28349322.
9: Hope SF, et al. A systematic review of economic evaluations of population-based sodium
reduction interventions. PLoS One. 2017 Mar 29;12(3):e0173600. PMID: 28355231.
10: Hunt B, Mocarski M, Valentine WJ, Langer J. IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting. Diabetes Ther. 2017 Mar 27. PMID:28349444.
11: Karnon J, et al. A Cost-Effectiveness Model for Frail Older Persons: Development and Application to a Physiotherapy-Based Intervention. Appl Health Econ Health Policy. 2017 Mar 27. PMID: 28349499.
12: Lee TH, Kim W, Shin J, Park EC, Park S, Kim TH. Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea. Cancer Res Treat. 2017 Mar 30. PMID: 28361522.
13: Leung W, et al. Economic evaluation of an exercise-counselling intervention to enhance smoking cessation outcomes: The Fit2Quit trial. Tob Induc Dis. 2017 Mar 29;15:21. PMID:
14: Nishie A, et al. Cost-Effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan. Clin Ther. 2017 Mar 28. PMID: 28363694.
15: Pichler H, et al. Cost-Effectiveness of Defibrotide in the Prophylaxis of Veno-Occlusive Disease Following Pediatric Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 Mar 27. PMID: 28359910.
16: Tamoschus D, Draexler K, Chang J, Ngai C, Madin-Warburton M, Pitcher A. Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in Germany. Clin Drug Investig. 2017 Mar 30. PMID: 28361439.
17: Vega-Hernandez G, Wojcik R, Schlueter M. Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK. Diabetes Ther. 2017 Mar 27. PMID: 28349443.
18: Zhou K, Wen F, Zhang P, Zhou J, Chen H, Zheng H, Yang Y, Li Q. Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer. Clin Transl Oncol. 2017 Mar 28. PMID: 28353006.
19: Cost-effectiveness of regular versus irregular supportive periodontal therapy or tooth removal. Br Dent J. 2017 Mar 24;222(6):438. PMID: 28337007.
20: Achoki T, Lesego A. The imperative for systems thinking to promote access to medicines, efficient delivery, and cost-effectiveness when implementing health financing reforms: a qualitative study. Int J Equity Health. 2017 Mar 21;16(1):53. PMID: 28327143.
21: Brunetti ND, De Gennaro L, Caldarola P, Gaglione A, Di Biase M. Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend? Int J Cardiol. 2017 Mar 22. PMID: 28363685.
22: Carlson JJ, Canestaro W, Ravelo A, Wong W. The cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib. J Med Econ. 2017 Mar 23:1-7. PMID: 28332433.
23: Clark LA, Whitmire S, Patton S, Clark C, Blanchette CM, Howden R. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease. J Med Econ. 2017 Mar 23:1-17. PMID: 28332417.
24: Dieleman JM, et al. DExamethasone for Cardiac Surgery (DECS) Study Group. Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial. Anaesthesia. 2017 Mar 20. PMID: 28317094.
25: Earnshaw SR, McDade CL, Chu Y, Fleige LE, Sievenpiper JL. Cost-Effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary Prevention. Clin Ther. 2017 Mar 24. PMID: 28347513.
26: Edmond KM, Strobel NA, McAuley K, Geelhoed E, Hurt L. Economic evaluation of interventions delivered by primary care providers to improve neurodevelopment in children aged under 5 years: protocol for a scoping review. Syst Rev. 2017 Mar 21;6(1):59.PMID: 28327185.
27: Iscoe M, Lord R, Schulz J, Lee D, Cayea D, Pahwa A. Teaching medical students about cost-effectiveness. Clin Teach. 2017 Mar 21. PMID: 28322509.
28: Le LK, Barendregt JJ, Hay P, Sawyer SM, Paxton SJ, Mihalopoulos C. The modelled cost-effectiveness of cognitive dissonance for the prevention of anorexia nervosa and bulimia nervosa in adolescent girls in Australia. Int J Eat Disord. 2017 Mar 21. PMID: 28323355.
29: Luni Y, Borakati A, Matah A, Skeats K, Eedarapalli P. A prospective cohort study evaluating the cost-effectiveness of carbetocin for prevention of postpartum haemorrhage in caesarean sections. J Obstet Gynaecol. 2017 Mar 20:1-7.PMID: 28317421.
30: Matter-Walstra K, Schwenkglenks M, Dedes KJ. Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting. Breast Cancer Res Treat. 2017 Mar 21. PMID: 28321586.
31: Mercier G, Loureiro M, Georgescu V, Skalli EM, Nedelcu M, Ramadan M, Fabre JM, Lefebvre P, Nocca D. Surgical glue in laparoscopic sleeve gastrectomy: An initial experience and cost-effectiveness analysis. J Eval Clin Pract. 2017 Mar 21. PMID: 28322488.
32: Moriwaki K, Mouri M, Hagino H. Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan. Osteoporos Int. 2017 Mar 21. PMID: 28324132.
33: Paquete AT, Miguel LS, Becker U, Pereira C, Pinto CG. Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy. Appl Health Econ Health Policy. 2017 Mar 24. PMID: 28342061.
34: Ramachandran A, Manabe Y, Rajasingham R, Shah M. Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda. BMC Infect Dis. 2017 Mar 23;17(1):225. PMID: 28335769.
35: Schwendicke F, Stolpe M. Cost-effectiveness of Different Post-retained Restorations. J Endod. 2017 Mar 23. pii: S0099-2399(17)30004-3. PMID: 28343930.
36: Tajeu GS, Mennemeyer S, Menachemi N, Weech-Maldonado R, Kilgore M. Cost-effectiveness of Antihypertensive Medication: Exploring Race and Sex Differences Using Data From the REasons for Geographic and Racial Differences in Stroke Study. Med Care. 2017 Mar 22. PMID: 28333708.
37: Tappenden P, Sadler S, Wildman M. An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis. Pharmacoeconomics. 2017 Mar 23. PMID: 28337719.
38: Thom H, Jackson C, Welton N, Sharples L. Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling. Pharmacoeconomics. 2017 Mar 24.PMID: 28342114.
39: Whelan ME, Goode AD, Eakin EG, Veerman JL, Winkler EA, Hickman IJ, Reeves MM.
Erratum to: Feasibility, effectiveness and cost-effectiveness of a telephone-based weight loss program delivered via a hospital outpatient setting. Transl Behav Med. 2017 Mar 23. PMID: 28337721.
40: Wijnen BF, de Kinderen RJ, Lambrechts DA, Postulart D, Aldenkamp AP, Majoie MH, Evers SM. Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy. Epilepsy Res. 2017 Mar 21;132:91-99. PMID: 28364726.